perfluorohexyloctane Miebo
Selected indexed studies
- Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial. (JAMA Ophthalmol, 2023) [PMID:36929413]
- Perfluorohexyloctane ophthalmic solution (Miebo) for dry eye disease. (Med Lett Drugs Ther, 2024) [PMID:38212258]
- Perfluorohexyloctane. (, 2006) [PMID:39836820]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Perfluorohexyloctane. (2006) pubmed
- Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease. (2024) pubmed
- Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial. (2023) pubmed
- Perfluorohexyloctane: More than Meets the Eye? (2026) pubmed
- Quintessence of currently approved and upcoming treatments for dry eye disease. (2025) pubmed
- Perfluorohexyloctane ophthalmic solution (Miebo) for dry eye disease. (2024) pubmed
- Perfluorohexyloctane Ophthalmic Solution (Miebo) for Dry Eye. (2025) pubmed
- In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease. (2023) pubmed
- Perfluorohexyloctane Eye Drops in Premenopausal and Postmenopausal Women with Dry Eye Disease Associated with Meibomian Gland Dysfunction: A Post Hoc Analysis of a Phase 3 Trial. (2026) pubmed
- Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics. (2025) pubmed